# EIF4EBP2

## Overview
EIF4EBP2 is a gene that encodes the eukaryotic translation initiation factor 4E binding protein 2 (4E-BP2), a key regulator of protein synthesis. As a translation repressor, 4E-BP2 binds to eIF4E, a component of the eIF4F complex, inhibiting the initiation of cap-dependent mRNA translation. This interaction is modulated by the phosphorylation state of 4E-BP2, which influences its binding affinity to eIF4E and, consequently, its regulatory function (Sonenberg2009Regulation). 4E-BP2 is predominantly expressed in the brain, particularly in regions associated with synaptic plasticity and memory formation, such as the hippocampus (Banko2005The). The protein plays a significant role in cellular responses to stress and nutrient availability by integrating signals from pathways like PI3K/Akt/mTOR (Hoeffer2010mTOR). Alterations in the EIF4EBP2 gene have been linked to neurodevelopmental disorders, including autism spectrum disorders, highlighting its clinical significance (AguilarValles2015Inhibition).

## Structure
EIF4EBP2 is a protein that plays a crucial role in regulating translation by binding to eIF4E, thereby inhibiting its interaction with the eIF4F complex. The primary structure of EIF4EBP2 consists of a sequence of amino acids that form the basis for its function. In terms of secondary structure, EIF4EBP2 includes both alpha helices and beta sheets, which contribute to its stability and functional conformation.

The tertiary structure of EIF4EBP2 involves the three-dimensional folding of these secondary structural elements, allowing it to effectively interact with eIF4E. This folding is essential for its role in translation regulation. EIF4EBP2 functions as a monomer and, as such, lacks a quaternary structure.

Post-translational modifications, particularly phosphorylation, are common in EIF4EBP2. These modifications significantly impact its binding affinity to eIF4E, thereby modulating its inhibitory function. Phosphorylation serves as a regulatory mechanism, influencing the protein's activity in response to various cellular signals. The absence of a quaternary structure and the presence of specific post-translational modifications highlight the unique aspects of EIF4EBP2's molecular structure and its role in cellular processes.

## Function
EIF4EBP2 encodes the eukaryotic translation initiation factor 4E binding protein 2, which plays a crucial role in regulating protein synthesis in healthy human cells. This protein functions as a translation repressor by binding to eIF4E, a component of the eIF4F complex, thereby inhibiting the initiation of cap-dependent mRNA translation. The interaction between EIF4EBP2 and eIF4E is regulated by phosphorylation; when EIF4EBP2 is hypophosphorylated, it binds strongly to eIF4E, preventing the formation of the eIF4F complex and thus repressing translation (Sonenberg2009Regulation).

EIF4EBP2 is highly expressed in the brain, particularly in the hippocampus, where it is involved in synaptic plasticity and memory formation. In the absence of EIF4EBP2, as observed in knock-out mice, there is an increase in the formation of the eIF4F complex, leading to enhanced translation initiation. This results in facilitated long-term potentiation (LTP), a process essential for memory consolidation, although it can also lead to impairments in spatial learning and memory due to excessive translation (Banko2005The).

EIF4EBP2 is active in the cytoplasm, where it influences cellular responses to stress and nutrient availability, integrating signals from pathways such as PI3K/Akt/mTOR to modulate protein synthesis (Hoeffer2010mTOR).

## Clinical Significance
Mutations or alterations in the EIF4EBP2 gene, which encodes the translation repressor 4E-BP2, have been implicated in autism spectrum disorders (ASDs). The deletion of this gene leads to an imbalance in excitatory-to-inhibitory neurotransmission, resulting in ASD-like behaviors in animal models. This is linked to exacerbated mRNA translation during brain development, which is a contributing factor to ASDs (AguilarValles2015Inhibition). Eif4ebp2-null mice exhibit impaired social interaction and repetitive behaviors, which are characteristic of ASDs. These phenotypes can be reversed by antagonists of group I metabotropic glutamate receptors (mGluR1 and mGluR5), suggesting potential therapeutic targets for treating ASD symptoms associated with EIF4EBP2 deficiency (AguilarValles2015Inhibition).

The EIF4EBP2 gene is also involved in synaptic plasticity and memory formation. In 4E-BP2 knock-out mice, there is a conversion of early-phase long-term potentiation (LTP) to late-phase LTP, which is associated with impaired spatial learning and memory. This suggests that proper regulation of the eIF4F complex by 4E-BP2 is crucial for learning and memory processes in the hippocampus (Banko2005The). These findings highlight the importance of EIF4EBP2 in neurological functions and its potential role in neurodevelopmental disorders.

## Interactions
EIF4EBP2, also known as eukaryotic translation initiation factor 4E-binding protein 2, interacts with several proteins, playing a crucial role in regulating protein synthesis. It binds to eIF4E, a component of the eIF4F complex, inhibiting the assembly of this complex and thus controlling translation initiation. This interaction is modulated by the phosphorylation state of EIF4EBP2, which, when phosphorylated, reduces its affinity for eIF4E, allowing translation to proceed (TsukiyamaKohara1996Tissue).

In the context of cerebral ischemia, EIF4EBP2 interacts with Dihydropyrimidinase-related protein 2 (DRP2). This interaction is influenced by the phosphorylation state of DRP2, which affects its binding affinity to EIF4EBP2 and eIF4E. During ischemic reperfusion, hyperphosphorylated DRP2 isoforms show increased association with EIF4EBP2 and eIF4E, particularly in the hippocampal CA1 region, potentially inhibiting protein synthesis and contributing to neuronal death (MartínezAlonso2023DihydropyrimidinaseRelated).

EIF4EBP2 also plays a role in synaptic plasticity and memory. In knockout mice lacking EIF4EBP2, there is an increase in the formation of the eIF4F complex, which is involved in cap-dependent translation initiation, indicating that EIF4EBP2 is critical for regulating eIF4F complex formation during long-term potentiation (Banko2005The).


## References


[1. (AguilarValles2015Inhibition) A. Aguilar-Valles, E. Matta-Camacho, A. Khoutorsky, C. Gkogkas, K. Nader, J.-C. Lacaille, and N. Sonenberg. Inhibition of group i metabotropic glutamate receptors reverses autistic-like phenotypes caused by deficiency of the translation repressor eif4e binding protein 2. Journal of Neuroscience, 35(31):11125–11132, August 2015. URL: http://dx.doi.org/10.1523/JNEUROSCI.4615-14.2015, doi:10.1523/jneurosci.4615-14.2015. This article has 64 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1523/JNEUROSCI.4615-14.2015)

[2. (Hoeffer2010mTOR) Charles A. Hoeffer and Eric Klann. Mtor signaling: at the crossroads of plasticity, memory and disease. Trends in Neurosciences, 33(2):67–75, February 2010. URL: http://dx.doi.org/10.1016/j.tins.2009.11.003, doi:10.1016/j.tins.2009.11.003. This article has 890 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.tins.2009.11.003)

[3. (Banko2005The) Jessica L. Banko, Francis Poulin, Lingfei Hou, Christine T. DeMaria, Nahum Sonenberg, and Eric Klann. The translation repressor 4e-bp2 is critical for eif4f complex formation, synaptic plasticity, and memory in the hippocampus. The Journal of Neuroscience, 25(42):9581–9590, October 2005. URL: http://dx.doi.org/10.1523/JNEUROSCI.2423-05.2005, doi:10.1523/jneurosci.2423-05.2005. This article has 361 citations.](https://doi.org/10.1523/JNEUROSCI.2423-05.2005)

[4. (MartínezAlonso2023DihydropyrimidinaseRelated) Emma Martínez-Alonso, Alejandro Escobar-Peso, Natalia Guerra-Pérez, Marcel Roca, Jaime Masjuan, and Alberto Alcázar. Dihydropyrimidinase-related protein 2 is a new partner in the binding between 4e-bp2 and eif4e related to neuronal death after cerebral ischemia. International Journal of Molecular Sciences, 24(9):8246, May 2023. URL: http://dx.doi.org/10.3390/ijms24098246, doi:10.3390/ijms24098246. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24098246)

[5. (Sonenberg2009Regulation) Nahum Sonenberg and Alan G. Hinnebusch. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell, 136(4):731–745, February 2009. URL: http://dx.doi.org/10.1016/j.cell.2009.01.042, doi:10.1016/j.cell.2009.01.042. This article has 2602 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2009.01.042)

[6. (TsukiyamaKohara1996Tissue) Kyoko Tsukiyama-Kohara, Silvia M. Vidal, Anne-Claude Gingras, Thomas W. Glover, Samir M. Hanash, Henry Heng, and Nahum Sonenberg. Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4e-binding proteins 1 and 2. Genomics, 38(3):353–363, December 1996. URL: http://dx.doi.org/10.1006/geno.1996.0638, doi:10.1006/geno.1996.0638. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/geno.1996.0638)